Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Petrovic, I; Dobric, I; Drmic, D; Sever, M; Klicek, R; Radic, B; Brcic, L; Kolenc, D; Zlatar, M; Kunjko, K; Jurcic, D; Martinac, M; Rasic, Z; Boban Blagaic, A; Romic, Z; Seiwerth, S; Sikiric, P.
BPC 157 therapy to detriment sphincters failure-esophagitis-pancreatitis in rat and acute pancreatitis patients low sphincters pressure.
J Physiol Pharmacol. 2011; 62(5): 527-534.
[OPEN ACCESS]
Web of Science
PubMed
- Co-authors Med Uni Graz
- Brcic Luka
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Abstract:
- Possibly, acute esophagitis and pancreatitis cause each other, and we focused on sphincteric failure as the common causative key able to induce either esophagitis and acute pancreatitis or both of them, and thereby investigate the presence of a common therapy nominator. This may be an anti-ulcer pentadecapeptide BPC 157 (tested for inflammatory bowel disease, wound treatment) affecting esophagitis, lower esophageal and pyloric sphincters failure and acute pancreatitis (10 μg/kg, 10 ng/kg intraperitoneally or in drinking water). The esophagitis-sphincter failure procedure (i.e., insertion of the tubes into the sphincters, lower esophageal and pyloric) and acute pancreatitis procedure (i.e., bile duct ligation) were combined in rats. Esophageal manometry was done in acute pancreatitis patients. In rats acute pancreatitis procedure produced also esophagitis and both sphincter failure, decreased pressure 24 h post-surgery. Furthermore, bile duct ligation alone immediately declines the pressure in both sphincters. Vice versa, the esophagitis-sphincter failure procedure alone produced acute pancreatitis. What's more, these lesions (esophagitis, sphincter failure, acute pancreatitis when combined) aggravate each other (tubes into sphincters and ligated bile duct). Counteraction occurred by BPC 157 therapies. In acute pancreatitis patients lower pressure at rest was in both esophageal sphincters in acute pancreatitis patients. We conclude that BPC 157 could cure esophagitis/sphincter/acute pancreatitis healing failure.
- Find related publications in this database (using NLM MeSH Indexing)
- Acute Disease -
- Administration, Oral -
- Animals -
- Anti-Ulcer Agents - administration & dosage Anti-Ulcer Agents - therapeutic use
- Disease Models, Animal -
- Dose-Response Relationship, Drug -
- Endoscopy, Digestive System -
- Esophageal Sphincter, Lower - drug effects Esophageal Sphincter, Lower - physiopathology
- Esophagitis - drug therapy Esophagitis - etiology Esophagitis - pathology
- Female -
- Humans -
- Injections, Intraperitoneal -
- Male -
- Manometry -
- Middle Aged -
- Pancreatitis - drug therapy Pancreatitis - etiology Pancreatitis - pathology
- Peptide Fragments - administration & dosage Peptide Fragments - therapeutic use
- Pressure -
- Proteins - administration & dosage Proteins - therapeutic use
- Rats -
- Rats, Wistar -
- Treatment Outcome -
- Find related publications in this database (Keywords)
- acute pancreatitis
- esophagitis
- pancreatitis
- pentadecapeptide BPC 157
- sphincters failure